CLINICAL_TRIALS
trial_result
· 2019-12-17
Clinical Trial Update: Liraglutide In Overweight Patients With Type 1 Diabetes [Phase 3]
Summary
Phase 3 clinical trial updating liraglutide use in overweight patients with type 1 diabetes has completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University at Buffalo | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2019-12-17